Rare Genetic
- Business
Takeda to Acquire Maverick Therapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio
Osaka, Japan & Brisbane, Calif., United States: Acquisition expands Takeda’s immuno-oncology portfolio with two development candidates and Maverick’s conditionally active…
Read More » -
Takeda Completes Sale of Select OTC and Non-Core Assets to Hypera Pharma
Osaka, Japan: Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of…
Read More » - United States
Takeda Achieves Industry-Leading Positions in 2021 Access to Medicine Index
Osaka, Japan & Cambridge, Mass., United States: Company Ranked Sixth Overall and Leads the Pharmaceutical Industry in Governance of Access…
Read More » - Business
Takeda to Present at The 39th Annual J.P. Morgan Healthcare Conference
Osaka, Japan & Cambridge, Mass., United States: Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) (“Takeda”) will present virtually at the…
Read More »